Cargando…
Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I
Mucopolysaccharidosis (MPS) type I is a rare lysosomal storage disorder caused by an accumulation of glycosaminoglycans (GAGs) resulting in multisystem disease. Neurological morbidity includes hydrocephalus, spinal cord compression, and cognitive decline. While many neurological symptoms have been d...
Autores principales: | Grant, Nathan, Taylor, J. Michael, Plummer, Zach, Myers, Kasiani, Burrow, Thomas, Luchtman-Jones, Lori, Byars, Anna, Hammill, Adrienne, Wusick, Katie, Smith, Edward, Leach, James, Vadivelu, Sudhakar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224401/ https://www.ncbi.nlm.nih.gov/pubmed/34178879 http://dx.doi.org/10.3389/fped.2021.606905 |
Ejemplares similares
-
Treatment of latent tuberculosis in a child with mucopolysaccharidosis type I receiving enzyme replacement therapy: A case report
por: Vasilevska, Lauma, et al.
Publicado: (2022) -
Review of the use of idursulfase in the treatment of mucopolysaccharidosis II
por: Burrow, T Andrew, et al.
Publicado: (2008) -
Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
por: Li, Ying, et al.
Publicado: (2022) -
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022) -
SUN-065 Bone Health Outcomes in a Large, Diverse Pediatric Cohort Undergoing Hematopoietic Stem Cell Transplant
por: Swauger, Sarah, et al.
Publicado: (2020)